The outlines of a massive solar thermal power plant—the largest ever—are starting to appear in the wilderness outside of Las Vegas. The $2.2 billion project, which is being built by Oakland, California-based BrightSource, stretches over 3,600 acres near Ivanpah, California. When it’s finished, it will generate 370 megawatts of electricity on sunny days.
The project has been a long time coming. BrightSource first filed an application for the project in the summer of 2007. Approval took three years. Construction was temporarily slowed to accommodate the care and relocation of desert tortoises—a threatened species—found in larger numbers than expected. The project, which will generate electricity by using mirrors to concentrate sunlight to heat up water and drive steam turbines, is now expected to be finished next year.
Even as the project nears completion, the future of solar thermal power plants is in doubt. That’s in large part because prices for solar panels—which convert sunlight to electricity directly—have dropped quickly in the last few years, causing at least one company to abandon plans to build solar thermal plants in favor of making ones that use solar panels.
Yet solar thermal has at least one great strength compared to many other types of solar power: the heat it produces is easy to store, so electricity can be generated even after the sun goes down, and power can be dispatched to the grid whenever it’s most needed.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.